Clinical trials
Terminated Phase 1 Lymphoma, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 4 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| Fate Therapeutics | 2 |
| TG Therapeutics, Inc. | 2 |
| The Lymphoma Academic Research Organisation | 2 |
| University of California, San Francisco | 2 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 1 |
| AbbVie | 1 |
| Adicet Therapeutics | 1 |
| Affimed GmbH | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 32 |
| Lymphoma, Non-Hodgkin | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Lymphoma | 7 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Lymphoma, Mantle-Cell | 6 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Recurrence | 5 |
| Burkitt Lymphoma | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.